Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Conditionally active chimeric antigen receptors for modified t-cells

Conditionally active chimeric antigen receptors for modified t-cells

US Patent 11111288 · Granted Sep 7, 2021

Estimated economic value: $20,126,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multi-specific antibody constructs2025
Multi-specific antibody constructs2025
Multi-specific antibody constructs2025
Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconj2025
Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconj2025
Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconj2025
Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereo2025
Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereo2025
Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereo2025
Antibody molecules to LAG-3 and uses thereof2025
Antibody molecules to LAG-3 and uses thereof2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2025